Real time, image guided high flow CED in recurrent glioblastoma (rGBM); initial experience from phase 2 study of a targeted immunotherapy, MDNA55 (cpIL-4PE).

Research output: Contribution to conferencePresentation

Original languageAmerican English
StatePublished - 2017
EventCNS -
Duration: Jan 1 2017 → …

Conference

ConferenceCNS
Period1/1/17 → …

Disciplines

  • Medicine and Health Sciences

Cite this